Vioxx was created to combat the effects of osteoarthritis (OA) and rheumatoid arthritis (RA). When Merck introduced Vioxx in 1999 it was an unparalleled scientific breakthrough in this area. Vioxx was heralded as the future of pain medications and was rushed to the shelves by both Merck and the FDA.

Osteoarthritis and rheumatoid arthritis are among the most prevalent chronic illnesses and leading causes of disability in the United States. The enzymes responsible for these two ...MORE